Provided by Tiger Trade Technology Pte. Ltd.

ORUKA THERAPEUTICS INC

92.11
-0.5100-0.55%
Post-market: 92.110.00000.00%17:02 EDT
Volume:596.16K
Turnover:54.79M
Market Cap:6.10B
PE:-45.50
High:93.20
Open:90.78
Low:90.27
Close:92.62
52wk High:115.52
52wk Low:14.67
Shares:66.21M
Float Shares:56.55M
Volume Ratio:0.69
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0242
EPS(LYR):-1.8483
ROE:-18.23%
ROA:-12.95%
PB:5.49
PE(LYR):-49.83

Loading ...

Does Oruka Therapeutics' (ORKA) $1 Billion Shelf Plan Reframe Its Long-Term Capital Strategy?

Simply Wall St.
·
Apr 06

BRIEF-Oruka Therapeutics May Offer Up To $1 Billion Of Securities From Time To Time - SEC Filing

Reuters
·
Apr 03

Oruka Therapeutics Files $1 Billion Mixed Shelf

MT Newswires Live
·
Apr 03

Oruka Therapeutics files $1B mixed securities shelf

TIPRANKS
·
Apr 03

Oruka Therapeutics Inc - May Offer up to $1 Bln of Securities From Time to Time - SEC Filing

THOMSON REUTERS
·
Apr 03

ORKA-001 Phase 1 Completion: What Oruka’s First-in-Human Milestone Means for Investors

TIPRANKS
·
Apr 02

Piper Sandler Sticks to Their Buy Rating for Oruka Therapeutics (ORKA)

TIPRANKS
·
Mar 24

Stock Track | Oruka Therapeutics Soars 9% in Pre-market After Leerink Partners Raises Price Target to $86

Stock Track
·
Mar 16

Oruka Therapeutics' Shares Hit 52-Week High, 4Q Loss Narrower Than Expected

Dow Jones
·
Mar 13

Stock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades

Stock Track
·
Mar 13

Analysts Offer Insights on Healthcare Companies: Citius Oncology (CTOR) and Oruka Therapeutics (ORKA)

TIPRANKS
·
Mar 13

Oruka Therapeutics (ORKA) Receives a Buy from Guggenheim

TIPRANKS
·
Mar 13

Oruka Therapeutics Inc : Stifel Raises Target Price to $72 From $47

THOMSON REUTERS
·
Mar 13

Jefferies Remains a Buy on Oruka Therapeutics (ORKA)

TIPRANKS
·
Mar 11

Oruka’s ORKA-001 Extension Study Builds Long-Term Case in Psoriasis Market

TIPRANKS
·
Mar 07

Oruka Therapeutics COO Laura Lee Sandler Disposes of Common Shares

Reuters
·
Mar 03

Oruka Therapeutics Inc expected to post a loss of 63 cents a share - Earnings Preview

Reuters
·
Mar 02